C12Y 108/99
Oxidoreductases acting on sulfur groups as donors: with other acceptors
Official title: with other acceptors (1.8.99)
C12Y108/99 (Oxidoreductases acting on sulfur groups as donors: with other acceptors) appears on 13 US grants and 24 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 24
- Assignees
- 12
- Inventors
- 42
- Latest grant
- 17 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 3 |
| 2018 | 1 | 1 |
| 2019 | 1 | 3 |
| 2020 | 2 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 3 |
| 2023 | 3 | 1 |
| 2024 | 2 | 1 |
| 2025 | 0 | 2 |
By publication year.
Subgroups
Granted patents
Recent patents
- Method of co-expressing a sulfatase and a sulfatase modifying factor in a plant or plant cell17 Dec 2024US 12,168,784 B2Biostrategies Lc
- Activated formylglycine-generating enzymes and methods of producing and using the same25 Jun 2024US 12,018,308 B2R.P. Scherer Technologies, LLC
- Antibody conjugates and methods of making and using the same17 Oct 2023US 11,788,066 B2R.P. Scherer Technologies, LLC
- Probiotic compositions and uses thereof27 Jun 2023US 11,684,643 B2
- Activated formylglycine-generating enzymes and methods of producing and using the same23 May 2023US 11,655,492 B2R.P. Scherer Technologies, LLC
- Compositions and methods for treating metachromatic leukodystrophy disease and related disorders17 Jul 2025US 2025/0228907 A1The Children’s Hospital of Philadelphia
- Method of Co-Expressing a Sulfatase and a Sulfatase Modifying Factor in a Plant or Plant Cell17 Apr 2025US 2025/0122483 A1Biostrategies Lc
- Antibody Conjugates and Methods of Making and Using the Same28 Mar 2024US 2024/0101975 A1
- Activated Formylglycine-Generating Enzymes and Methods of Producing and Using the Same9 Nov 2023US 2023/0357814 A1R.P. Scherer Technologies, LLC
- Materials and methods for treating disorders associated with sulfatase enzymes11 Aug 2022US 2022/0251522 A1Biostrategies Lc
Most cited
By later US patents
- Cell that expresses a sulfatase and a formylglycine generating enzyme22US 8,227,212 B2Shire Human Genetic Therapies, Inc. · 2012
- Methods and compositions for nucleoside triphosphate and ribonucleic acid production3US 10,858,385 B2GreenLight Biosciences, Inc. · 2020
- Method for producing L-cysteine3US 9,234,223 B2Ajinomoto Co., Inc. · 2016
- Activated formylglycine-generating enzymes and methods of producing and using the same1US 9,951,367 B2R.P. Scherer Technologies, LLC · 2018